News & Videos - ORGANOVO HOLDINGS INC.

Thinking about buying stock in Arcutis Biotherapeutics, Energy Transfer, Brilliant Acquisition, UiPath, or Organovo? PR Newswire NEW YORK, Dec. 18, 2023 NEW YORK , Dec. 18, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ARQT, ET, BRLI, PATH, and ONVO. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. ARQT:...

Organovo Founder Keith Murphy sent the following letter to company shareholders: At the Organovo annual shareholder meeting in September, I heard a lot of voices asking how Organovo’s technology could help the company out of its position. Shareholders seemed perplexed that with $30 million and an incredible technology portfolio, there was no way forward. I agreed with that sentiment, but also, in my opinion as a stockholder, Organovo’s failure was a failure of its Board and management, so I...

...

Organovo Holdings, Inc. (“Organovo”) (Nasdaq: ONVO) and Tarveda Therapeutics, Inc. (“Tarveda”), a privately-held, clinical stage biopharmaceutical company developing a new class of potent and selective precision oncology medicines, which it refers to as Pentarin miniature drug conjugates, today announced that they have entered into a definitive merger agreement under which Tarveda would merge with a wholly-owned subsidiary of Organovo in an all-stock transaction. Upon completion of the...

...

...

...

...

...

...

...

...

NEW YORK, NY / ACCESSWIRE / February 8, 2018 / Organovo Holdings, Inc. (NASDAQ: ONVO ) will be discussing their earnings results in their Q3 Earnings Call to be held on February 8, 2018 at 5:00 PM Eastern Time. To listen to the event live or access a replay of the call - visit https://www.investornetwork.com/company/3601 To receive updates for this company you can register by emailing [email protected] or by clicking get investment info from the company's profile. About Investor Network...

NEW YORK, NY / ACCESSWIRE / August 9, 2017 / Organovo Holdings, Inc. (NASDAQ: ONVO ) will be discussing their earnings results in their Q1 Earnings Call to be held on Wednesday, August 9, 2017 at 5:00 PM Eastern Time. To listen to the event live - visit https://www.investornetwork.com/company/3601 . Replay Information The replay will be available online at https://www.investornetwork.com/company/3601 . About Investor Network Investor Network (IN) is a financial content community, serving...

VIDEO FINANCIAL REPORTING Why invest in is the first financial video platform where you can easily search through thousands of videos describing global ......

SAN DIEGO and MELBOURNE, Australia and SPRINGFIELD, Va., Jan. 24, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using its 3D bioprinting technology, today announced a collaboration with Professor Melissa Little and the Murdoch Childrens Research Institute, The Royal Children’s Hospital, Melbourne, Australia to develop an architecturally correct kidney for potential...

SAN DIEGO, Jan. 19, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using its 3D bioprinting technology, will host a conference call on Thursday, February 9, 2017 at 5:00 p.m. Eastern Time (ET) to discuss the Company's fiscal third-quarter 2017 financial results. In advance of the call on February 9, 2017, Organovo will issue its fiscal third-quarter 2017 earnings press...

SAN DIEGO, Dec. 14, 2016 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using its 3D bioprinting technology, announced an exclusive distributor agreement with Cosmo Bio Co., Ltd. (JASDAQ:3386) (“CosmoBio”) for its NovoView TM Preclinical Services in Japan. CosmoBio is one of Japan’s largest suppliers in the life science industry, and Organovo will work with...

SAN DIEGO, Dec. 13, 2016 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using its 3D bioprinting technology, is presenting the first data showing survival and sustained functionality of its 3D bioprinted human liver tissue when implanted into animal models. This data is being presented at the TERMIS-Americas Meeting in San Diego. “With a critical shortage of donor organs...

Organovo to Present on December 14 in a Live Interactive Webcast at VirtualInvestorConferences.com PR Newswire SAN DIEGO, Dec. 7, 2016 SAN DIEGO , Dec. 7, 2016 /PRNewswire/ -- Organovo Holdings, Inc. (NASDAQ:ONVO) ("Organovo"), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using its 3D bioprinting technology, today announced that Chairman and Chief Executive Officer Keith Murphy is scheduled to speak at VirtualInvestorConferences.com on Wednesday,...